Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars

Journal
Presentation
    （Last updated : 2023-11-22 15:01:20）
  Azuma Naoto
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Relapsing polychondritis coexisting with immune thrombocytopenic purpura: an unusual association. 2013/04
2. Original article　 Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sjögren's syndrome. 2013/11
3. Original article　 Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. 2019/05 Link
4. Original article　 Relationship between YKL-40 and Pulmonary Arterial Hypertension in Systemic Sclerosis. 2019/05
5. Original article　 Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. 2019/05
6. Case report　 Efficacy of using trimethoprim-sulfamethoxazole prophylaxis in an adult patient with autoimmune neutropenia. 2019/09
7. Original article　 Delayed onset of metronidazole-induced encephalopathy in a patient with systemic sclerosis accompanied by intestinal pseudo-obstruction. 2020/01
8. Original article　 Recurrent myocardial infarction associated with vasculo-Behçet's disease: a case report. 2020/07
9. Original article　 Evaluation of changes in oral health-related quality of life over time in patients with Sjögren's syndrome. 2021/05
10. Original article　 Clinical value of the threshold derived from bone single-photon emission computed tomography/computed tomography in differentiating sternoclavicular arthritis. 2022/01
11. Original article　 Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis. 2022/01
12. Original article　 Abatacept Ameliorates Both Glandular and Extraglandular Involvements in Patients With Sjögren's Syndrome Associated with Rheumatoid Arthritis: Findings from an Open-Label, Multicenter, 1-Year, Prospective Study: the ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren's Syndrome Endocrinopathy) and ROSE II trials. 2022/02
13. Original article　 Arm heating to relieve Raynaud's phenomenon in systemic sclerosis: A single-arm multicentre prospective clinical trial. 2022/09
14. Original article　 Effectiveness of apremilast against Behçet's disease-associated mucocutaneous and joint involvement confirmed through switching from adalimumab. 2022/09
15. Case report　 Quantitative bone SPECT/CT for evaluating treatment response in patient with sternoclavicular arthritis. 2022/10
16. Original article　 Serum B cell activating factor(BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis. 2022/12
17. Original article　 Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren's syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospective study: The ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren's Syndrome Endocrinopathy) and ROSE II trials. 2023/01
18. Original article　 The role of pain catastrophizing in pain perception among patients with rheumatoid arthritis without clinical signs of inflammation. 2023/02
19. Case report　 Cytomegalovirus-associated splenic infarction in rheumatoid arthritis. 2023/03
20. Case report　 nfarctus Splénique associé au cytomegalovirus dans la polyarthrite rheumatoïde. 2023/10
Display 5 items
Display all(20)
■ Presentation
1. Effect of abatacept on bone homeostasis and osteopontin in rheumatoid arthritis. （Poster presentation，General Lecture） 2013/06/15
2. Soluble interleukin-2 receptor levels and the CD4/CD8 ratio as predictors of the efficacy of abatacept in biologics-naïve rheumatoid arthritis patients. （Poster presentation，General Lecture） 2013/10/29
3. Immune-related Adverse events induced by cancer immunotherapies. Big data analysis of 13,051cases (immunocancer international registry). （Poster presentation，General Lecture） 2019/06/13
4. Phenotypic clusters of rheumatic/systemic immune-related adverse events induced by cancer immunotherapies (immunocancer international registry). （Poster presentation，General Lecture） 2019/06/13
5. Systemic Immune-inflammation index in rheumatoid arthritis patients:relation to disease activity. （Poster presentation，General Lecture） 2019/06/13
6. Circulating cell free DNA released from eosinophils is a practical biomarker in patients with eosinophilic granulomatosis with polyangiitis. （Poster presentation，General Lecture） 2019/11/11
7. Evaluation of changes in oral health-related quality of life over time in patients with Sjögren’syndrome. （Poster presentation，General Lecture） 2019/11/11
8. Relationship between YKL-40, VEGF, and IL-5 in borderline mPAP and pulmonary hypertension in systemic sclerosis. （Poster presentation，General Lecture） 2019/11/11
9. A usability survey of wrist mounted disposable heat pad on raynaud’s phenomenon in patients with connective tissue diseases. （Poster presentation，General Lecture） 2020/07/03
10. The baseline soluble GP130 is associated with the response of rheumatoid arthritis patients to sarilmab. （Poster presentation，General Lecture） 2020/07/03
11. Circulating cell free DNA as a biomarker in Eosinophilic granulomatosis with polyangiitis. （Web announcement，Symposium/Workshop/Panel Discussion） 2020/09/17
12. Pregnancy-related hemophagocytic lymphohistiocytosis: a report of three cases with assessing cytokines profile. （Web announcement，General Lecture） 2020/09/17
13. Wrist mounted disposable heat pad is a highly practical heating method for connective tissue diseases patients presenting with Raynaud’s Phenomenon. 22nd Asia-Pacific League of Associations for Rheumatology
Virtual Congress (APLAR2020) （Web announcement，General Lecture） 2020/10/24
14. Increased levels of serum wisteria floribunda agglutininpositive Mac-2 binding protein in rheumatic diseases including SLE. （Newspaper announcement） 2021/06/02
15. Successful treatment of checkpoint inhibitor-induced arthritis with the IL-6 receptor inhibitor Sarilumab. （Poster presentation，General Lecture） 2021/08/28
16. Plasma cell-free DNA is a useful biomarker for tocilizumab therapy in rheumatoid arthritis. （Poster presentation，General Lecture） 2021/11/08
17. Neutrophil count reduction 1month after initiating sarilumab and baseline serum soluble gp130 levels can independently predict clinical remission within 3 month in rheumatoid arthritis patients. （Newspaper announcement） 2022/06/01
18. Sodium bicarbonate mouth rinse is a useful self-care method for dry mouth in patients with sjögren’syndrome. （Newspaper announcement） 2022/06/01
19. The baseline serum soluble TNF receptor level are associated with the response of rheumatoid arthritis
patients to JAKinibs. （Newspaper announcement） 2022/06/01
20. YKL-40-mediated Inflammatory pathogenesis common to polymyositis/dermatomyositis. （Poster presentation，General Lecture） 2022/10/14
21. Predictive factors for the flare of patients with rheumatoid arthritis (RA) in ultrasound remission(US-R). （Poster presentation，General Lecture） 2023/06/01
22. Eosinophil activation as a biomarker for discriminating active and remission phase in ANCA-Associated vasculitis. （Poster presentation，General Lecture） 2023/11/14
23. Comparative evaluation of CLIA and EIA assays for the Detection of Antiphospholipid Antibodies. （Poster presentation，General Lecture） 2023/12
24. Similar effect of co-administration of methotrexate and folic acid for the treatment of rheumatoid arthritis compared with separate administration. （Poster presentation，General Lecture） 2023/12
Display 5 items
Display all(24)
mail